4-(n-(iodoacetoxy)ethyl-n-methyl)amino-7-nitrobenz-2-oxa-1,3-diazole has been researched along with epigallocatechin gallate in 1 studies
Studies (4-(n-(iodoacetoxy)ethyl-n-methyl)amino-7-nitrobenz-2-oxa-1,3-diazole) | Trials (4-(n-(iodoacetoxy)ethyl-n-methyl)amino-7-nitrobenz-2-oxa-1,3-diazole) | Recent Studies (post-2010) (4-(n-(iodoacetoxy)ethyl-n-methyl)amino-7-nitrobenz-2-oxa-1,3-diazole) | Studies (epigallocatechin gallate) | Trials (epigallocatechin gallate) | Recent Studies (post-2010) (epigallocatechin gallate) |
---|---|---|---|---|---|
50 | 0 | 3 | 5,456 | 173 | 3,403 |
Protein | Taxonomy | 4-(n-(iodoacetoxy)ethyl-n-methyl)amino-7-nitrobenz-2-oxa-1,3-diazole (IC50) | epigallocatechin gallate (IC50) |
---|---|---|---|
Chain A, POLYMERASE PA | Influenza A virus | 1.9 | |
Chain A, Polymerase Pa | Influenza A virus (A/California/04/2009(H1N1)) | 1.9 | |
Chain A, Polymerase Pa | Influenza A virus (A/California/04/2009(H1N1)) | 1.9 | |
Chain A, Polymerase Pa | Influenza A virus (A/California/04/2009(H1N1)) | 1.9 | |
Chain A, Polymerase Pa | Influenza A virus (A/California/04/2009(H1N1)) | 1.9 | |
Prostaglandin E synthase | Homo sapiens (human) | 1.8 | |
Telomerase reverse transcriptase | Homo sapiens (human) | 1.0867 | |
NAD kinase | Homo sapiens (human) | 0.96 | |
Urokinase-type plasminogen activator | Homo sapiens (human) | 0.091 | |
Tissue-type plasminogen activator | Homo sapiens (human) | 0.091 | |
Polymerase acidic protein | Influenza A virus (A/Puerto Rico/8/1934(H1N1)) | 5.86 | |
Amyloid-beta precursor protein | Homo sapiens (human) | 2.7 | |
Plasminogen activator inhibitor 1 | Homo sapiens (human) | 0.091 | |
Urokinase-type plasminogen activator | Mus musculus (house mouse) | 0.091 | |
ATP-dependent translocase ABCB1 | Homo sapiens (human) | 0.1233 | |
72 kDa type IV collagenase | Homo sapiens (human) | 4.3833 | |
Hepatocyte growth factor receptor | Homo sapiens (human) | 10 | |
Matrilysin | Homo sapiens (human) | 3.34 | |
Enoyl-[acyl-carrier-protein] reductase [NADH] FabI | Escherichia coli K-12 | 5 | |
Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 1.15 | |
Apoptosis regulator Bcl-2 | Homo sapiens (human) | 0.45 | |
Microtubule-associated protein tau | Homo sapiens (human) | 1.8 | |
60 kDa heat shock protein, mitochondrial | Homo sapiens (human) | 2.3 | |
Glucose-6-phosphate 1-dehydrogenase | Saccharomyces cerevisiae S288C | 0.25 | |
Lethal factor | Bacillus anthracis | 0.097 | |
Phosphoglycerate mutase 1 | Homo sapiens (human) | 0.49 | |
DNA (cytosine-5)-methyltransferase 1 | Homo sapiens (human) | 0.5 | |
Proteasome subunit beta type-5 | Homo sapiens (human) | 0.543 | |
DNA repair protein RAD52 homolog | Homo sapiens (human) | 2.5108 | |
Matrix metalloproteinase-14 | Homo sapiens (human) | 6.8 | |
4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6 | Homo sapiens (human) | 3.34 | |
Squalene monooxygenase | Rattus norvegicus (Norway rat) | 0.69 | |
6-phosphogluconate dehydrogenase, decarboxylating | Homo sapiens (human) | 0.72 | |
BH3-interacting domain death agonist | Homo sapiens (human) | 1.0733 | |
Beta-secretase 1 | Homo sapiens (human) | 1.1785 | |
10 kDa heat shock protein, mitochondrial | Homo sapiens (human) | 2.3 | |
Bcl-2-like protein 1 | Homo sapiens (human) | 0.59 | |
Induced myeloid leukemia cell differentiation protein Mcl-1 | Homo sapiens (human) | 0.92 | |
Alpha-(1,3)-fucosyltransferase 7 | Homo sapiens (human) | 3.34 | |
CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1 | Homo sapiens (human) | 3.34 | |
Dual specificity tyrosine-phosphorylation-regulated kinase 1A | Homo sapiens (human) | 0.3055 | |
Mitogen-activated protein kinase 14 | Homo sapiens (human) | 2.21 | |
Bcl-2-related protein A1 | Homo sapiens (human) | 1.79 | |
Thiosulfate sulfurtransferase | Homo sapiens (human) | 7.3 | |
60 kDa chaperonin | Escherichia coli | 0.47 | |
Sigma non-opioid intracellular receptor 1 | Cavia porcellus (domestic guinea pig) | 10 | |
Dual specificity tyrosine-phosphorylation-regulated kinase 1A | Rattus norvegicus (Norway rat) | 0.33 | |
Reverse transcriptase/RNaseH | Human immunodeficiency virus 1 | 0.73 | |
10 kDa chaperonin | Escherichia coli | 0.47 | |
3-oxoacyl-[acyl-carrier-protein] reductase | Plasmodium falciparum 3D7 | 0.32 | |
MAP kinase-activated protein kinase 5 | Homo sapiens (human) | 1 | |
Bcl-2-like protein 2 | Homo sapiens (human) | 2.33 | |
Enoyl-acyl-carrier protein reductase | Plasmodium falciparum (malaria parasite P. falciparum) | 0.225 | |
3-oxoacyl-acyl-carrier protein reductase | Plasmodium falciparum (malaria parasite P. falciparum) | 0.3 | |
Beta-hydroxyacyl-ACP dehydratase precursor (Fatty acid synthesis protein) | Plasmodium falciparum (malaria parasite P. falciparum) | 0.215 | |
Bcl-2-like protein 10 | Homo sapiens (human) | 0.36 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Casciano, CN; Clement, RP; Johnson, WW; Wang, EJ | 1 |
1 other study(ies) available for 4-(n-(iodoacetoxy)ethyl-n-methyl)amino-7-nitrobenz-2-oxa-1,3-diazole and epigallocatechin gallate
Article | Year |
---|---|
Fluorescent substrates of sister-P-glycoprotein (BSEP) evaluated as markers of active transport and inhibition: evidence for contingent unequal binding sites.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Binding Sites; Biological Transport, Active; Biomarkers; Cells, Cultured; Drug Interactions; Fluorescent Dyes; Humans | 2003 |